| 1 |
tumor necrosis factor-alpha
(47624 times)
|
Allergy and Immunology
(6681 times)
|
IL-6 (8021 times)
IL-1beta (6403 times)
LPS (5583 times)
|
0 Tumor Necrosis Factor Alpha Signaling in Trigeminal Ganglion Contributes to Mechanical Hypersensitivity in Masseter Muscle During Temporomandibular Joint Inflammation.
|
| 2 |
alpha-tumor necrosis factor
(10 times)
|
Obstetrics
(3 times)
|
IL-1beta (2 times)
ADG (1 time)
ALT (1 time)
|
2000 Effects of nickel sulfate on pulmonary natural immunity in Wistar rats.
|
| 3 |
transforming growth factor-alpha
(6 times)
|
Biochemistry
(3 times)
|
COX-2 (3 times)
IL-10 (2 times)
IL-6 (2 times)
|
2008 Accelerated Ulcer Healing and Resistance to Ulcer Recurrence with Gastroprotectants in Rat Model of Acetic Acid-induced Gastric Ulcer.
|
| 4 |
transforming necrosis factor alpha
(5 times)
|
Allergy and Immunology
(2 times)
|
CRP (1 time)
ELISA (1 time)
ICAM-I (1 time)
|
1999 Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes.
|
| 5 |
Tumor necrosis factor-alpha/cachectin
(5 times)
|
Allergy and Immunology
(2 times)
|
anti-hTNF-alpha (1 time)
Bo rIFN-gamma (1 time)
BP (1 time)
|
1987 Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
|
| 6 |
concentration,tumor necrosis factor-alpha
(2 times)
|
Critical Care
(1 time)
|
ALI (1 time)
BALF (1 time)
BMI (1 time)
|
2015 Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
|
| 7 |
treated with antitumour necrosis factor-alpha
(2 times)
|
Medicine
(1 time)
|
---
|
2014 Anti-TNF-alpha and risk of infections: the experience in one center.
|
| 8 |
tumor inflammatory factor-alpha
(2 times)
|
Veterinary Medicine
(2 times)
|
AST (2 times)
LPS (2 times)
APS (1 time)
|
2019 Effects of Clostridium butyricum and Enterococcus faecalis on growth performance, intestinal structure, and inflammation in lipopolysaccharide-challenged weaned piglets.
|
| 9 |
Anti-Tnf-alpha/FNAB/PC-Au for protein biomarker
(1 time)
|
Biotechnology
(1 time)
|
FNAB (1 time)
PBS-T20 (1 time)
PC (1 time)
|
2017 On-chip electrochemical immunoassay platform for specific protein biomarker estimation in undiluted serum using off-surface membrane matrix.
|
| 10 |
non-smokers.Tumor necrosis factor-alpha
(1 time)
|
Pulmonary Medicine
(1 time)
|
BAL (1 time)
COPD (1 time)
IL-6 (1 time)
|
2014 Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
|
| 11 |
pathways—tumor necrosis factor-alpha
(1 time)
|
Dermatology
(1 time)
|
IL-23 (1 time)
Th17 (1 time)
|
2020 Real-World Clinical Experience With the IL-17 Receptor A Antagonist Brodalumab
|
| 12 |
production--tumour necrosis factor-alpha
(1 time)
|
Virology
(1 time)
|
EIAV (1 time)
HIV (1 time)
IFN-alpha (1 time)
|
1997 Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia.
|
| 13 |
T cell, could activate neither macrophage production of inflammatory cytokines
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1996 Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.
|
| 14 |
thymus and spleen weights as well as serum necrosis factor-alpha
(1 time)
|
Biochemistry
(1 time)
|
IL-2 (1 time)
MW (1 time)
Se (1 time)
|
2016 Anti-tumor and immunomodulatory activity of selenium (Se)-polysaccharide from Se-enriched Grifola frondosa.
|
| 15 |
transcription factor NF-kappaB, an enhanced production of proinflammatory cytokines
(1 time)
|
|
HGF (1 time)
NPs (1 time)
|
2019 Molecular Responses in THP-1 Macrophage-Like Cells Exposed to Diverse Nanoparticles.
|
| 16 |
treatment strategies for Crohn's disease including antitumor necrosis factor-alpha
(1 time)
|
Pediatrics
(1 time)
|
GH (1 time)
IGF (1 time)
IL-6 (1 time)
|
2011 The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients.
|
| 17 |
tube dilution method, lymphocyte proliferation, and pro-inflammatory cytokines
(1 time)
|
Pharmacology
(1 time)
|
---
|
2015 Immunosuppressive potential of Botryosphaeria dothidea, an endophyte isolated from Kigelia africana.
|
| 18 |
tumor levels of necrosis factor-alpha
(1 time)
|
Clinical Laboratory Techniques
(1 time)
|
ARDS (1 time)
IL-6 (1 time)
MDA (1 time)
|
2018 Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS.
|
| 19 |
tumor necreactive oxygen speciesis factor-alpha
(1 time)
|
Pharmacology
(1 time)
|
AD (1 time)
COX-2 (1 time)
GCLM (1 time)
|
2017 L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-kappaB inhibition and Nrf2 pathway activation.
|
| 20 |
tumor necrosis alpha-factor
(1 time)
|
Medicine
(1 time)
|
---
|
1996 [Correlation between histocompatibility antigens, tumor necrosis factor-alpha, and HIV infection].
|
| 21 |
tumor necrosis factor-alpha expression
(1 time)
|
Biochemistry
(1 time)
|
IL-1 (1 time)
|
1997 Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release from cytotrophoblastic BeWo cells independently of induction of the TNF-alpha mRNA.
|
| 22 |
Tumor Necrosis Factor-alpha serum concentration
(1 time)
|
Biology
(1 time)
|
---
|
1996 Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
|
| 23 |
tumour necrosis factor alpha superfamily
(1 time)
|
Biochemistry
(1 time)
|
TL1A (1 time)
|
2019 Tumour necrosis factor like cytokine 1A levels and lesion complexity in non-smoking patients with coronary artery disease.
|
| 24 |
tumour necrosis factor-alpha production
(1 time)
|
Cell Biology
(1 time)
|
IA (1 time)
|
2018 Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
|
| 25 |
type and number of infiltrating cells, changes in protein, cytokine
(1 time)
|
Dermatology
(1 time)
|
DNFB (1 time)
EGFRIs (1 time)
SCF (1 time)
|
2011 Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
|
A Search Service for Abbreviation / Long Form